Patient P-02466
Synthetic patientMETA-24 · Day 173 · 25–34 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
56%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S20
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+29
- Nutritional resilience-21
- Inflammatory activity+13
- Treatment adherence-4
What helped?
No interventions yet.
LIFE OS recommendation
Monitoring Escalation ME-01
77%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 100% showed improvement
- median effect visible after 3 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Glucose, CGM daily mean
CGM141 mg/dL
stable · +1.3 vs previous 14 d
Active minutes
Wearable67 min
stable · +1.4 vs previous 14 d
Sleep duration
Wearable5.7 h
stable · -0.2 vs previous 14 d
Energy level
Daily log5.5/10
stable · -0.2 vs previous 14 d
Steps
Wearable7,691
stable · -137 vs previous 14 d
GI burden
Companion37.4/100
worsening · +7.0 vs previous 14 d
Adherence
Companion91.6 %
stable · -2.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 75 from the failing basin, 20 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -5.2 next day on high-intake days · n 22
Would not help
- Keep simple carbs lowGI +5.2 next day on high-intake days · n 17
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Simple carbohydrates+5.2detractor · 95%
- Protein-5.2supporter · 95%
- Ultra-processed food+1.5no signal · 33%
- Insoluble fibre+1.2no signal · 22%
- Dietary fat load+0.8no signal · 15%
- Alcohol-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
- Autonomic recovery ↓20
- WearableShort sleep window
- Mucosal barrier integrity ↓10
- WearableSleep 5.7 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
Microbiome
Shannon diversity 2.9 · butyrate capacity 47/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 58 ms
- Sleep
- 6.4 h
- Steps
- 8,545
- Resting HR
- 66 bpm
Daily log: GI score 37, nutritional resilience 55, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02275 | 45% | S01 | — | — | 84 |
| P-02138 | 42% | S01 | — | — | 79 |
| P-02282 | 40% | S01 | BR-03 | no change | 88 |
| P-02342 | 40% | S01 | — | — | 76 |
| P-02592 | 40% | S01 | — | — | 74 |
| P-02257 | 38% | S01 | — | — | 81 |
| P-02555 | 37% | S01 | AD-05 | no change | 79 |
| P-02204 | 35% | S01 | — | — | 70 |
| P-02620 | 35% | S01 | HY-01 | improved | 64 |
| P-02137 | 33% | S01 | — | — | 81 |
| P-02354 | 33% | S01 | CR-01 | improved | 78 |
| P-02424 | 33% | S01 | — | — | 62 |